Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Asentar: Phase II started

NOVC began a placebo-controlled Phase II trial in 132 patients with advanced pancreatic adenocarcinoma

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE